China Pharmaceuticals & Healthcare Q4 2019
China will continue to benefit from significant investment from the innovative pharmaceutical industry. While theChinese pharmaceutical market continues to face uncertainty on the back of challenges around drug pricing and the low levels ofintellectual property protection, we maintain our view that it presents one of the most attractive investment destinations in the AsiaPacific region. Underpinning this view, China boasts a number of inherent advantages that makes it well positioned for continuedFDI flows into the pharmaceutical sector. These include: a rapidly ageing population, a well-established manufacturing industry forpharmaceuticals and notable government commitment to sector development.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook